BUY SYMBIOTEC PHARMALAB LTD — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)1 Oct 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Symbiotec Pharmalabs shares surge 19% to a new post-listing high after 10-year deal with European protein innovator
NewsCnbc-Tv18·6 Nov · 2d ago
Symbiotec Pharmalab has entered into a 10-year take-or-pay agreement to manufacture fermentation-based alternative protein for a European innovator.
BSE · Company Update·6 Nov · 2d ago
Symbiotec Pharmalab Gets Motilal Oswal's 'Buy' Initiation; Check Target Price
NewsNdtv-Profit·26 Oct · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on SYMBIOTEC PHARMALAB
- BUY — Motilal Oswal7 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY — JM Financial27 Oct 2026 · ~1 year · target ₹1,622 · Target hit
- BUY — Motilal Oswal26 Oct 2026 · ~1 year · target ₹1,430 · Target hit
More from ICICI Securities
- BUY Star Cement13 Nov 2026 · ~1 year · target ₹215 · Active
- BUY Lemon Tree Hotels13 Nov 2026 · ~1 year · target ₹150 · Active
- BUY Hindustan Aeronautics13 Nov 2026 · ~1 year · target ₹5,820 · Active
- BUY K.P.R. Mill12 Nov 2026 · ~1 year · target ₹1,400 · Active
- BUY Kalyan Jewellers India12 Nov 2026 · ~1 year · target ₹800 · Active

